Table 3. Comparisons between the IDH1-mutant group and the IDH1-wild-type group in LrGGs and GBMs.
Metric | IDH1 wild-type | IDH1 mutant | P value |
---|---|---|---|
LrGG | |||
ALPS-index | 1.400±0.185 | 1.530±0.123 | 0.036 |
FA-tumor | 0.153±0.060 | 0.112±0.046 | 0.015 |
MD-tumor | 1.103±0.313 | 1.426±0.359 | 0.019 |
MK-tumor | 0.627±0.193 | 0.462±0.114 | 0.003 |
FA-edema | 0.193±0.076 | 0.169±0.065 | 0.364 |
MD-edema | 1.332±0.340 | 1.485±0.199 | 0.144 |
MK-edema | 0.549±0.118 | 0.489±0.068 | 0.129 |
GBM | |||
ALPS-index | 1.300±0.169 | 1.380±0.110 | 0.175 |
FA-tumor | 0.174±0.111 | 0.142±0.075 | 0.448 |
MD-tumor | 0.985±0.247 | 0.947±0.300 | 0.781 |
MK-tumor | 0.685±0.170 | 0.690±0.187 | 0.999 |
FA-edema | 0.194±0.081 | 0.183±0.071 | 0.736 |
MD-edema | 1.421±0.279 | 1.249±0.350 | 0.186 |
MK-edema | 0.535±0.096 | 0.579±0.143 | 0.274 |
Data are presented as mean ± standard deviation. MD is in units of 10−3 mm2/s. IDH1, isocitrate dehydrogenase 1; LrGG, lower-grade glioma; GBM, glioblastoma; ALPS, analysis along the perivascular space; FA, fractional anisotropy; MD, mean diffusivity; MK, mean kurtosis.